Skip to main content
Top
Gepubliceerd in: Research on Child and Adolescent Psychopathology 6/2020

14-04-2020

U.S. Child Behavioral Health Quality Measures: Advancing a National Research Agenda

Auteur: Bonnie T. Zima

Gepubliceerd in: Research on Child and Adolescent Psychopathology | Uitgave 6/2020

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

This paper is based on the keynote presentation for the biennial meeting of the International Society for Research on Child and Adolescent Psychopathology (ISRCAP) in Los Angeles, California. The topic was purposively selected to raise awareness of how the measurement of child behavioral health care quality at the national level, and corresponding standards for reliability and clinical validity, substantially differ from those traditionally applied to the measurement of child psychopathology. Under a federal mandate, an initial Core Set of quality measures for children was created for voluntary reporting by State Medicaid agencies. The four national child behavioral health quality measures in the 2019 Child Core Set encompass timeliness of care, vary by child age range, and two different types of psychotropic medication treatments. Measures are described and implications for data interpretation are provided. Findings are summarized from: 1) a systematic literature review; 2) State adherence rates; and 3) ten-year national trends in adherence rates by health plan type. Scientific evidence supporting the clinical validity of the measures is scarce, statewide adherence rates widely vary, and improvement over time has been modest. Nevertheless, State Medicaid agencies will be mandated to report measure adherence rates beginning in 2024. Together, these findings stimulate recommendations for health policies to allocate additional resources for data infrastructure to monitor child mental health care quality and identify areas for future research.
Literatuur
go back to reference Becker, E. R., Constantine, R. J., McPherson, M. A., & Jones, M. E. (2013). Antipsychotic polypharmacy prescribing patterns and costs in the Florida adult and child Medicaid populations. Journal of Health Care Finance, 40(1), 40–67.PubMed Becker, E. R., Constantine, R. J., McPherson, M. A., & Jones, M. E. (2013). Antipsychotic polypharmacy prescribing patterns and costs in the Florida adult and child Medicaid populations. Journal of Health Care Finance, 40(1), 40–67.PubMed
go back to reference Berwick, D. M., Nolan, T. W., & Whittington, J. (2008). The triple aim: Care, health, and cost. Health Affairs, 27(3), 759–769.PubMedCrossRef Berwick, D. M., Nolan, T. W., & Whittington, J. (2008). The triple aim: Care, health, and cost. Health Affairs, 27(3), 759–769.PubMedCrossRef
go back to reference Blackburn, J., Becker, D. J., Morrisey, M. A., Kilgore, M. L., Sen, B., Caldwell, C., et al. (2017). An assessment of the CHIP/Medicaid quality measure for ADHD. The American Journal of Managed Care, 23(1), e1–e9.PubMed Blackburn, J., Becker, D. J., Morrisey, M. A., Kilgore, M. L., Sen, B., Caldwell, C., et al. (2017). An assessment of the CHIP/Medicaid quality measure for ADHD. The American Journal of Managed Care, 23(1), e1–e9.PubMed
go back to reference Brinkman, W. B., Baum, R., Kelleher, K. J., Peugh, J., Gardner, W., Lichtenstein, P., et al. (2016). Relationship between attention-deficit/hyperactivity disorder care and medication continuity. Journal of the American Academy Child & Adolescent Psychiatry., 55(4), 289–294.CrossRef Brinkman, W. B., Baum, R., Kelleher, K. J., Peugh, J., Gardner, W., Lichtenstein, P., et al. (2016). Relationship between attention-deficit/hyperactivity disorder care and medication continuity. Journal of the American Academy Child & Adolescent Psychiatry., 55(4), 289–294.CrossRef
go back to reference Bussing, R., Narwaney, K. J., Winterstein, A. G., Newton, D. A., DeBar, L., Boscarino, J. A., et al. (2014). Pharmacotherapy for incident attention-deficit/hyperactivity disorder: Practice patterns and quality metrics. Current Medical Research and Opinion., 30(8), 1687–1699.PubMedCrossRef Bussing, R., Narwaney, K. J., Winterstein, A. G., Newton, D. A., DeBar, L., Boscarino, J. A., et al. (2014). Pharmacotherapy for incident attention-deficit/hyperactivity disorder: Practice patterns and quality metrics. Current Medical Research and Opinion., 30(8), 1687–1699.PubMedCrossRef
go back to reference Carroll A.E., Bauer N.S., Dugan T.M., Anand V., Saha C., Downs S.M (2013).Use of a computerized decision aid for ADHD diagnosis: a randomized controlled trial. Pediatrics. 2013:peds-2013. Carroll A.E., Bauer N.S., Dugan T.M., Anand V., Saha C., Downs S.M (2013).Use of a computerized decision aid for ADHD diagnosis: a randomized controlled trial. Pediatrics. 2013:peds-2013.
go back to reference Cummings, J. R., Ji, X., Allen, L., Lally, C., & Druss, B. G. (2017). Racial and ethnic differences in ADHD treatment quality among Medicaid-enrolled youth. Pediatrics., 139(6), e20162444.PubMedPubMedCentralCrossRef Cummings, J. R., Ji, X., Allen, L., Lally, C., & Druss, B. G. (2017). Racial and ethnic differences in ADHD treatment quality among Medicaid-enrolled youth. Pediatrics., 139(6), e20162444.PubMedPubMedCentralCrossRef
go back to reference Epstein JN, Kelleher KJ, Baum R, Brinkman WB, Peugh J, Gardner W, et al. (2014). Variability in ADHD care in community-based pediatrics. Pediatrics.Peds-2014. Epstein JN, Kelleher KJ, Baum R, Brinkman WB, Peugh J, Gardner W, et al. (2014). Variability in ADHD care in community-based pediatrics. Pediatrics.Peds-2014.
go back to reference Finnerty, M., Neese-Todd, S., Pritam, R., Leckman-Westin, E., Bilder, S., Byron, S. C., et al. (2016). Access to psychosocial services prior to starting antipsychotic treatment among Medicaid-insured youth. Journal of the American Academy Child & Adolescent Psychiatry, 55(1), 69–76 e3.CrossRef Finnerty, M., Neese-Todd, S., Pritam, R., Leckman-Westin, E., Bilder, S., Byron, S. C., et al. (2016). Access to psychosocial services prior to starting antipsychotic treatment among Medicaid-insured youth. Journal of the American Academy Child & Adolescent Psychiatry, 55(1), 69–76 e3.CrossRef
go back to reference Fontanella, C. A., Hiance-Steelesmith, D. L., Bridge, J. A., Lester, N., Sweeney, H. A., Hurst, M., & Campo, J. V. (2015). Factors associated with timely follow-up care after psychiatric hospitalization for youths with mood disorders. Psychiatric Services, 67(3), 324–331.PubMedCrossRef Fontanella, C. A., Hiance-Steelesmith, D. L., Bridge, J. A., Lester, N., Sweeney, H. A., Hurst, M., & Campo, J. V. (2015). Factors associated with timely follow-up care after psychiatric hospitalization for youths with mood disorders. Psychiatric Services, 67(3), 324–331.PubMedCrossRef
go back to reference Geltman, P. L., Fried, L. E., Arsenault, L. N., Knowles, A. M., Link, D. A., Goldstein, J. N., Perrin, J. M., & Hacker, K. A. (2015). A planned care approach and patient registry to improve adherence to clinical guidelines for the diagnosis and management of attention-deficit/hyperactivity disorder. Academic Pediatrics., 15(3), 289–296.PubMedCrossRef Geltman, P. L., Fried, L. E., Arsenault, L. N., Knowles, A. M., Link, D. A., Goldstein, J. N., Perrin, J. M., & Hacker, K. A. (2015). A planned care approach and patient registry to improve adherence to clinical guidelines for the diagnosis and management of attention-deficit/hyperactivity disorder. Academic Pediatrics., 15(3), 289–296.PubMedCrossRef
go back to reference Heflinger, C. A., Shaw, V., Higa-McMillan, C., Lunn, L., & Brannan, A. M. (2015). Patterns of child mental health service delivery in a public system: Rural children and the role of rural residence. The Journal of Behavioral Health Services & Research., 42(3), 292–309.CrossRef Heflinger, C. A., Shaw, V., Higa-McMillan, C., Lunn, L., & Brannan, A. M. (2015). Patterns of child mental health service delivery in a public system: Rural children and the role of rural residence. The Journal of Behavioral Health Services & Research., 42(3), 292–309.CrossRef
go back to reference Institute of Medicine, Committee on Quality of Health Care in America. (2001) Crossing the quality chasm: A new health system for the 21st century. Washington D.C.: The National Academies Press. Institute of Medicine, Committee on Quality of Health Care in America. (2001) Crossing the quality chasm: A new health system for the 21st century. Washington D.C.: The National Academies Press.
go back to reference Larzelere, R. E., Kuhn, B. R., & Johnson, B. (2004). The intervention selection bias: An underrecognized confound in intervention research. Psychological Bulletin., 130(2), 289–303.PubMedCrossRef Larzelere, R. E., Kuhn, B. R., & Johnson, B. (2004). The intervention selection bias: An underrecognized confound in intervention research. Psychological Bulletin., 130(2), 289–303.PubMedCrossRef
go back to reference Leckman-Westin, E., Finnerty, M., Scholle, S. H., Pritam, R., Layman, D., Kealey, E., Byron, S., Morden, E., Bilder, S., Neese-Todd, S., Horwitz, S., Hoagwood, K., & Crystal, S. (2018). Differences in Medicaid antipsychotic medication measures among children with SSI, foster care, and income-based aid. Journal of Managed Care & Specialty Pharmacy., 24(3), 238–246.CrossRef Leckman-Westin, E., Finnerty, M., Scholle, S. H., Pritam, R., Layman, D., Kealey, E., Byron, S., Morden, E., Bilder, S., Neese-Todd, S., Horwitz, S., Hoagwood, K., & Crystal, S. (2018). Differences in Medicaid antipsychotic medication measures among children with SSI, foster care, and income-based aid. Journal of Managed Care & Specialty Pharmacy., 24(3), 238–246.CrossRef
go back to reference Patient Protection and Affordable Care Act, 42 U.S.C. § 18001 (2010). Patient Protection and Affordable Care Act, 42 U.S.C. § 18001 et seq. (2010). Patient Protection and Affordable Care Act, 42 U.S.C. § 18001 (2010). Patient Protection and Affordable Care Act, 42 U.S.C. § 18001 et seq. (2010).
go back to reference Rettew, D. C., Greenblatt, J., Kamon, J., Neal, D., Harder, V., Wasserman, R., Berry, P., MacLean, C. D., Hogue, N., & McMains, W. (2015). Antipsychotic medication prescribing in children enrolled in Medicaid. Pediatrics, 135(4), 658–665.PubMedCrossRef Rettew, D. C., Greenblatt, J., Kamon, J., Neal, D., Harder, V., Wasserman, R., Berry, P., MacLean, C. D., Hogue, N., & McMains, W. (2015). Antipsychotic medication prescribing in children enrolled in Medicaid. Pediatrics, 135(4), 658–665.PubMedCrossRef
go back to reference Saldaña, S. N., Keeshin, B. R., Wehry, A. M., Blom, T. J., Sorter, M. T., DelBello, M. P., & Strawn, J. R. (2014). Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 34(8), 836–844.CrossRef Saldaña, S. N., Keeshin, B. R., Wehry, A. M., Blom, T. J., Sorter, M. T., DelBello, M. P., & Strawn, J. R. (2014). Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 34(8), 836–844.CrossRef
go back to reference Thackeray, J., Crane, D., Fontanella, C., Sorter, M., Baum, R., & Applegate, M. (2018). A Medicaid quality improvement collaborative on psychotropic medication prescribing for children. Psychiatric Services, 69(5), 501–504.PubMedCrossRef Thackeray, J., Crane, D., Fontanella, C., Sorter, M., Baum, R., & Applegate, M. (2018). A Medicaid quality improvement collaborative on psychotropic medication prescribing for children. Psychiatric Services, 69(5), 501–504.PubMedCrossRef
go back to reference Toteja, N., Gallego, J. A., Saito, E., Gerhard, T., Winterstein, A., Olfson, M., & Correll, C. U. (2014). Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment. International Journal of Neuropsychopharmacology., 17(7), 1095–1105.PubMedCrossRef Toteja, N., Gallego, J. A., Saito, E., Gerhard, T., Winterstein, A., Olfson, M., & Correll, C. U. (2014). Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment. International Journal of Neuropsychopharmacology., 17(7), 1095–1105.PubMedCrossRef
go back to reference Sohn, M., Burgess, M., & Bazzi, M. (2017). Antipsychotic polypharmacy among children and young adults in office-based or hospital outpatient department settings. Pharmacy., 5(4), 64.CrossRef Sohn, M., Burgess, M., & Bazzi, M. (2017). Antipsychotic polypharmacy among children and young adults in office-based or hospital outpatient department settings. Pharmacy., 5(4), 64.CrossRef
go back to reference Williams, C. L., Cooper, W. O., Balmer, L. S., Dudley, J. A., Gideon, P. S., DeRanieri, M. M., et al. (2015). Evaluation and disposition of Medicaid-insured children and adolescents with suicide attempts. Academic Pediatrics., 15(1), 36–40.PubMedCrossRef Williams, C. L., Cooper, W. O., Balmer, L. S., Dudley, J. A., Gideon, P. S., DeRanieri, M. M., et al. (2015). Evaluation and disposition of Medicaid-insured children and adolescents with suicide attempts. Academic Pediatrics., 15(1), 36–40.PubMedCrossRef
go back to reference Zima, B. T., Marti, F. A., Lee, C. E., & Pourat, N. (2019b). Selection of a child clinical outcome measure for statewide use in publicly funded outpatient mental health programs. Psychiatric Services, 70(5), 381–388.PubMedCrossRef Zima, B. T., Marti, F. A., Lee, C. E., & Pourat, N. (2019b). Selection of a child clinical outcome measure for statewide use in publicly funded outpatient mental health programs. Psychiatric Services, 70(5), 381–388.PubMedCrossRef
go back to reference Zima, B. T., Norquist, G. S., Altchuler, S. I., Behrens, J., Iles-Shih, M. D., Ng, Y. K. W., & Schaepper, M. A. (2018). Office visits to monitor stimulant medication safety and efficacy: Recommended care. Journal of the American Academy of Child & Adolescent Psychiatry., 57(6), 438–439.CrossRef Zima, B. T., Norquist, G. S., Altchuler, S. I., Behrens, J., Iles-Shih, M. D., Ng, Y. K. W., & Schaepper, M. A. (2018). Office visits to monitor stimulant medication safety and efficacy: Recommended care. Journal of the American Academy of Child & Adolescent Psychiatry., 57(6), 438–439.CrossRef
Metagegevens
Titel
U.S. Child Behavioral Health Quality Measures: Advancing a National Research Agenda
Auteur
Bonnie T. Zima
Publicatiedatum
14-04-2020
Uitgeverij
Springer US
Gepubliceerd in
Research on Child and Adolescent Psychopathology / Uitgave 6/2020
Print ISSN: 2730-7166
Elektronisch ISSN: 2730-7174
DOI
https://doi.org/10.1007/s10802-020-00640-9

Andere artikelen Uitgave 6/2020

Research on Child and Adolescent Psychopathology 6/2020 Naar de uitgave